VetnCare's Second Deal in Six Weeks Signals a Faster Roll-Up Pace

Six weeks after its most recent veterinary hospital purchase, a Northern California roll-up backed by a healthcare-focused private equity firm is back with another one. VetnCare acquired Geary Veterinary Hospital, a nearly 50-year-old Walnut Creek practice, marking its seventh deal since partnering with Great Point Partners and the second under new CEO Matt Kirchner.

VetnCare buys Geary Veterinary Hospital in Walnut Creek

VetnCare announced Monday it has acquired Geary Veterinary Hospital, a Walnut Creek, California practice that has operated for nearly five decades under co-owners Dr. Gillian Hamilton, a former CDC epidemiologist, and Dr. Erica Weiss. Deal terms were not disclosed.

The hospital offers wellness care, preventive medicine, diagnostics, imaging, surgery, dental work, and senior pet care. VetnCare, an Oakland-based community of veterinary hospitals across Northern California, said the deal is its seventh acquisition since Great Point Partners, a Greenwich, Connecticut healthcare investment firm managing roughly $1.7 billion, first invested in the platform. It's also the second acquisition under CEO Matt Kirchner, who took the role earlier this year.

Kirchner said Geary has "built an exceptional reputation over nearly five decades by combining strong medicine with deep relationships" in the community. Hamilton and Weiss said their commitment to quality care for pets and their owners continues through the partnership.

Why the roll-up's deal pace just accelerated

VetnCare's previous acquisition, Holistic Veterinary Care, closed just six weeks earlier, on July 14. Before that, the platform had averaged roughly one deal every six months over three years under Great Point Partners' ownership, by VetnCare's own account of that transaction, in which it said it had "more than doubled its size" over that period. Two deals in six weeks is a different velocity than one deal every six months.

That kind of acceleration right after a CEO change is worth watching for anyone near the veterinary consolidation space, whether as a seller, a competitor, or a lender. Sponsors backing regional roll-ups frequently speed up dealmaking ahead of a broader sale of the platform itself. A faster acquisition cadence and a growing footprint, even one still confined to Northern California, make for a more attractive story to the next buyer, whether that's a larger consolidator or a strategic acquirer.

It's also a data point in a wider trend. Independent veterinary practices are still selling to private-equity-backed platforms at a steady clip, even in a year when some vet-sector consolidation has taken a different shape as VC-backed operators merge to compete with PE roll-ups rather than sell into one. A regional platform accelerating its buying, rather than pausing, suggests Great Point sees a favorable window to keep adding scale in Northern California specifically, ahead of any broader slowdown catching up with it.

For competing regional practices and other roll-ups eyeing the same geography, VetnCare's pace is a signal that the window to acquire desirable independent practices at reasonable multiples in this market may be narrowing.

Whether this pace holds or signals an exit prep

VetnCare hasn't said whether Geary marks the end of a burst of dealmaking or the start of a sustained faster pace.

We'll see whether VetnCare announces a third acquisition before year-end, which would confirm an accelerated cadence rather than a one-off coincidence of timing. Watch also whether Great Point Partners begins talking publicly about VetnCare's scale or geography beyond Northern California, since regional platforms usually signal an expansion push before they make it official. And watch the broader veterinary roll-up market for whether other PE-backed platforms match this pace, or whether VetnCare's acceleration is an outlier tied specifically to its new CEO settling in.

The clearest tell will come at the next deal, whenever it lands. A third acquisition inside a similarly tight window would say this is strategy, not coincidence.

Source: VetnCare via Business Wire